Genesis Pharmaceuticals Enterprises was granted SFDA approval for Radix Isatidis Dispersible Tablets. Radix Isatidis is a very popular traditional Chinese medicine used to treat the flu, though it was previously available only as a powder, which is dissolved in hot water. The Genesis formulation is the only dispersible tablet available. As a whole, Radix Isatidis is a $1.4 billion market annually. Genesis forecasts that it will manufacture and sell somewhere between $4 million and $10 million of its product in the next fiscal year (which ends June 30, 2009). More details...

Stock Symbol: (OTCBB: GTEC)